New Variants Mean COVID Vaccines, Tests May Need Tweaking: FDA
MONDAY, Feb. 22, 2021 (HealthDay News) — The emergence of new SARS-CoV-2 variants could require a quick pivot on the part of pharmaceutical and medical device companies, to help stay one step ahead of COVID-19. The U.S. Food and Drug Administration issued guidelines Monday encouraging drug and test developers toContinue Reading